Stordahl Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$436K Buy
363
+8
+2% +$8.17K 0.08% 50
2026
Q1
$327K Hold
355
0.07% 51
2025
Q4
$382K Hold
355
0.08% 47
2025
Q3
$271K Sell
355
-17
-5% -$12.7K 0.06% 53
2025
Q2
$290K Hold
372
0.06% 52
2025
Q1
$307K Buy
372
+22
+6% +$18.3K 0.07% 47
2024
Q4
$270K Hold
350
0.06% 50
2024
Q3
$310K Hold
350
0.07% 45
2024
Q2
$317K Hold
350
0.08% 44
2024
Q1
$272K Hold
350
0.07% 45
2023
Q4
$204K Sell
350
-40
-10% -$23.3K 0.06% 52
2023
Q3
$210K Buy
+390
New +$201K 0.06% 51

Other funds holding LLY

Stordahl Capital Management's LLY Position: Q2 2026 in Review

Stordahl Capital Management increased its Eli Lilly (LLY) stake by 2.3% in Q2 2026, buying an estimated $8.17K and bringing the position to 363 shares worth $436K. The position accounts for 0.08% of the portfolio, ranked #50.

Stordahl Capital Management first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Stordahl Capital Management held 363 shares of Eli Lilly worth $436K as of Q2 2026.
  • Stordahl Capital Management bought 8 Eli Lilly shares in Q2 2026, an estimated $8.17K.
  • Eli Lilly made up 0.08% of Stordahl Capital Management's portfolio in Q2 2026, its #50 holding.
  • Stordahl Capital Management first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Stordahl Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.